Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology
暂无分享,去创建一个
[1] Friedrich Leisch,et al. Sweave: Dynamic Generation of Statistical Reports Using Literate Data Analysis , 2002, COMPSTAT.
[2] Syed Mohsin,et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.
[3] Jeffrey S. Morris,et al. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..
[4] Wolfgang Huber,et al. A Compendium to Ensure Computational Reproducibility in High-Dimensional Classification Tasks , 2004, Statistical applications in genetics and molecular biology.
[5] Kevin R. Coombes,et al. Organ-Specific Differences in Gene Expression and Unigene Annotations Describing Source Material , 2004 .
[6] Cheng Cheng,et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.
[7] Sarah R. Edmonson,et al. High-resolution serum proteomic patterns for ovarian cancer detection. , 2004, Endocrine-related cancer.
[8] L. Liotta,et al. High-resolution serum proteomic patterns for ovarian cancer detection , 2004 .
[9] Jeffrey S. Morris,et al. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. , 2005, Journal of the National Cancer Institute.
[10] Ting Chen,et al. An integrated approach to the prediction of domain-domain interactions , 2006, BMC Bioinformatics.
[11] M. Relling,et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. , 2005, Cancer cell.
[12] W. Sauerbrei,et al. Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.
[13] Robert Gentleman,et al. Reproducible Research: A Bioinformatics Case Study , 2005, Statistical applications in genetics and molecular biology.
[14] H. Dressman,et al. Genomic signatures to guide the use of chemotherapeutics , 2006, Nature Medicine.
[15] C. Denkert,et al. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations , 2006, International journal of cancer.
[16] Robert Gentleman,et al. Statistical Analyses and Reproducible Research , 2007 .
[17] H. Dressman,et al. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] K. Coombes,et al. Microarrays: retracing steps , 2007, Nature Medicine.
[19] J. Nevins,et al. Reply to 'Microarrays: retracing steps' , 2007, Nature Medicine.
[20] J. Nevins,et al. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. , 2007, The Lancet. Oncology.
[21] Kevin R Coombes,et al. Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Anil Potti,et al. A genomic approach to identify molecular pathways associated with chemotherapy resistance , 2008, Molecular Cancer Therapeutics.
[23] Anil Potti,et al. An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer , 2008, PloS one.
[24] Cheng Li,et al. Automating dChip: toward reproducible sharing of microarray data analysis , 2008, BMC Bioinformatics.
[25] H. Dressman,et al. Corrigendum: Genomic signatures to guide the use of chemotherapeutics , 2008 .
[26] C. Ball,et al. Repeatability of published microarray gene expression analyses , 2009, Nature Genetics.
[27] J. Nevins,et al. Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma , 2009, Clinical Cancer Research.